Patients receiving quinolones and cyclosporine after heart transplantation.
Six patients required fluorinated quinolone therapy for a variety of infections after heart transplantation. In contrast to findings in a previous report, none of the patients showed any evidence of nephrotoxicity or required a significant change in cyclosporine dose during the treatment period.
Robinson
J A
JA
Stritch School of Medicine, Loyola University of Chicago, Maywood, IL 60153.
Venezio
F R
FR
Costanzo-Nordin
M R
MR
Pifarre
R
R
O'Keefe
P J
PJ
D001424:Bacterial Infections / Q000188:drug therapy*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D003524:Cyclosporins / Q000627:therapeutic use*; D016027:Heart Transplantation; D006801:Humans; D007165:Immunosuppression Therapy; D009643:Norfloxacin / Q000627:therapeutic use*
D003524:Cyclosporins; D002939:Ciprofloxacin; D009643:Norfloxacin